vindesine has been researched along with Carcinoma, Epidermoid in 150 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 77 (51.33) | 18.7374 |
1990's | 56 (37.33) | 18.2507 |
2000's | 15 (10.00) | 29.6817 |
2010's | 2 (1.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bella, AE; Fu, JH; Hu, Y; Luo, KJ; Wen, J; Xie, X; Yang, F; Yang, H; Zhang, SS | 1 |
Li, WF; Shao, XH; Xu, YS; Zhang, XQ | 1 |
Hayashi, E; Huang, CL; Kameyama, K; Liu, D; Okamoto, T; Yamamoto, Y; Yokomise, H | 1 |
Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X | 1 |
Vergnenègre, A | 1 |
Benedicic, Ch; Petru, E; Pickel, H; Seewann, A | 1 |
Imaizumi, M | 1 |
Funakoshi, Y; Kadota, Y; Kawamura, S; Koma, M; Maeda, H; Matsubara, Y; Takeda, S | 1 |
Coens, C; Kobierska, A; Lhomme, C; Namer, M; van der Burg, ME; van Luijk, IF; Vermorken, JB; Zanetta, G; Zola, P | 1 |
Araki, O; Ishihama, H; Karube, Y; Kobayashi, S; Miyoshi, S; Nagai, S; Sawabata, N; Seki, N; Tamura, M; Umezu, H; Yoshii, N | 1 |
Boku, N; Fukutomi, A; Hasuike, N; Hironaka, S; Inui, T; Ono, H; Onozawa, Y; Yamaguchi, Y; Yamazaki, K; Yasui, H; Yoshino, T | 1 |
Arnold, E; König, HJ; Sander, U; Walter, M | 1 |
Beyer, JH; Klee, M; Schröder, M; von Heyden, HW | 1 |
Alexander, J; Bains, M; Chapman, R; Hilaris, B; Hopfan, S; Kelsen, DP; Martini, N; McCormack, P | 1 |
Kelsen, DP | 1 |
Beyer, JH; Matthaei, A; Nagel, GA; Schröder, M; von Heyden, HW | 1 |
Bains, MS; Beattie, EJ; Kelsen, DP; Martini, N | 1 |
Braun, DW; Casper, ES; Chapman, RA; Golbey, R; Gralla, RJ; Heelan, RT; Howard, JE; Itri, LM; Kelsen, DP | 1 |
Beyer, JH; Borghardt, J; Caliebe, W; Gerhartz, H; Hofmann, J; Kastenbauer, E; Lissers, R; Nagel, GA; Rudert, H; Scherpe, A; Schneider, B; Schröder, M; Schroeder, M; von Heyden, HW; Westerhausen, M | 1 |
Bains, M; Coonley, C; Golbey, RB; Heelan, R; Hilaris, B; Kelsen, DP; Martini, N | 1 |
Bains, M; Chapman, R; Coonley, C; Dukeman, M; Heelan, R; Hilaris, B; Kelsen, D; Lesser, M | 1 |
Eguchi, K; Ohkura, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
Soukop, M | 1 |
Beyer, JH; Foth, B; Gerhartz, H; Kaboth, U; Kastenbauer, E; Nagel, GA; Scherpe, A; Schröder, M; Stennert, E; von Heyden, HW | 1 |
Scherpe, A; Schröder, M; Stennert, E; von Heyden, HW | 1 |
Beyer, JH; Hoffmann, H; Nagel, GA; Scherpe, A; Schneider, B; Schröder, M; Stennert, E; von Heyden, HW | 1 |
Conroy, JA; Kennedy, BJ; Peterson, BA; Vogelzang, NJ; Vosika, GJ | 1 |
Bitran, JD; Golomb, HM; Hoffman, PC | 1 |
Cartei, G; Ferrazzi, E; Fiorentino, MV; Galligioni, E; Pappagallo, GL; Vinante, O; Zagonel, V | 1 |
Eguchi, K; Saijo, N; Shibuya, M; Shimabukuro, Z; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
Bakowski, MT; Crouch, JC | 1 |
Clark, RA; Hutcheon, AW; Palmer, JB; Pratt, MA | 1 |
Broun, GO; Leavitt, J; Luedke, DW; Luedke, SL; Petruska, P; Schlueter, J | 1 |
Blum, RH; Foreman, JD; Muggia, FM | 1 |
Gatzemeier, U; Hossfeld, DK; Radenbach, D; Zschaber, R | 2 |
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B | 1 |
Akazawa, S; Futatsuki, K; Honda, T; Sampi, K | 1 |
Ahmedzai, S; Banham, SW; Calman, KC; Dorward, AJ; Elliott, JA; Hole, D; Kaye, SB; Stack, BH; Stevenson, RD | 1 |
Eguchi, K; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
Camacho, FJ; Kaplan, BH; O'Donnell, MR; Vogl, SE | 1 |
Clark, GM; Griffin, C; Mattox, DE; Sledge, GW; Von Hoff, DD | 1 |
Bromer, RH; Byrne, RE; Fofonoff, SA; Hoffer, SM; Hong, WK; Licciardello, JT; Popkin, JD; Strong, MS; Vaughan, CW; Welch, JM | 1 |
Braun, DW; Casper, ES; Dukeman, ME; Golbey, RB; Gralla, RJ; Kelsen, DP; Martini, N; Young, CW | 1 |
Dombernowsky, P; Hansen, HH; Hørbov, S; Osterlind, K; Rørth, M | 1 |
Broun, GO; Leavitt, J; Luedke, DW; Luedke, SL; Petruska, P; Reed, G | 1 |
Cobleigh, MA; Einhorn, LH; Furnas, BE; Williams, SD | 1 |
Ross, H; Ruffmann, R; Seifert, R; Sturm, E | 1 |
Arias, F; Dominguez, MA; Illarramendi, JJ; Lopez, R; Martinez, E; Tejedor, M; Valerdi, JJ | 1 |
Bernard, JP; Fournel, P; Jorda, M; Laennec, E; Piperno, D; Rebattu, P; Souquet, PJ; Trillet, V | 1 |
Ando, N; Iizuka, T; Kitajima, M; Ozawa, S | 1 |
Klocker, J; Raunik, W; Sabitzer, H; Schumer, J; Wieser, S | 2 |
Klinke, F; Micke, O; Rübe, C; von Eiff, M; Wagner, W; Willich, N | 1 |
Atarashi, K; Beppu, H; Nagashima, Y; Nodera, H; Tsukimoto, K; Yoshimura, N | 1 |
Gohma, I; Inoue, T; Kobashi, Y; Kohri, Y; Matsumura, Y; Mino, M; Oida, K; Taguchi, Y; Takano, Y; Tomii, K | 1 |
Cram, L; Gregor, A; Hansen, HH; Macbeth, FR; Paul, J | 1 |
Fujii, M; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Nakai, Y; Nakajima, S; Negoro, S; Takada, Y; Yamori, S | 1 |
Coldman, A; Coppin, C; Murray, N; Pater, J; Rapp, E | 1 |
Doi, O; Higashiyama, M; Kodama, K; Kuriyama, K; Yokouchi, H | 1 |
Bauer, J; Bernasconi, S; Leyvraz, S; Monnier, P; Pasche, P | 1 |
Arriagada, R; Douillard, JY; Lacombe-Terrier, MJ; Laplanche, A; Le Chevalier, T; Martin, M; Quoix, E; Ruffie, P; Tarayre, M | 1 |
Kaku, C; Kimura, O; Nabeya, K; Nakata, Y | 1 |
Mori, K; Suga, Y; Takahashi, T; Tominaga, K | 1 |
Miyazawa, N; Mori, T; Ohta, M; Sawamura, K; Shimoyama, M; Suemasu, K; Terashima, M; Tomita, M; Tsuchiya, R; Watanabe, Y | 1 |
Kimura, H; Yamaguchi, Y | 1 |
Higashino, K; Igarashi, T; Ikegami, H; Kawase, T; Komuta, K; Nakamura, S; Nakano, T; Nishikawa, H; Tachibana, T; Yokota, S; Yoshida, M | 1 |
Armand, JP; Bernal, ET; Cvitkovic, E; Domenge, C; Guillot, T; Janot, F; Sigal, R; Wibault, P | 1 |
Bertrand, P; Bockaert, J; De Beukelaar, T; De Muynck, P; Deman, R; Mariën, S; Roex, L; Ulrichts, H; Vandebroek, J; Vansteenkiste, J | 1 |
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Akiyama, Y; Fujii, Y; Kimura, S; Saito, S; Shirono, R | 1 |
Chimoto, M; Ikeda, Y; Ishihama, H; Kobayashi, S; Nagai, S; Shimada, K; Sugita, K; Umezu, H | 1 |
Fietkau, R; Iro, H; Kirschner, MJ; Sauer, R; Waldfahrer, F | 1 |
Ando, N; Arimori, M; Ide, H; Iizuka, T; Ishida, K; Isono, K; Kakegawa, T; Shinoda, M; Takiyama, W; Tanaka, O; Tsugane, S; Watanabe, H | 1 |
Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
Ciccone, AM; Coloni, GF; De Giacomo, T; Rendina, EA; Ricci, C; Ruvolo, G; Venuta, F | 1 |
Mikata, A; Mizutani, F; Nakamura, S; Sakao, S; Sasaki, Y; Tada, Y; Takiguchi, Y; Yagi, T; Yamagishi, F | 1 |
Bonvoisin, S; Desseigne, F; Gerard, JP; Morignat, E; Mornex, F; Pommier, P; Taieb, S; Vaillant, E | 1 |
Haneda, H; Hayashi, T; Koizumi, M | 1 |
Hebisawa, A; Mikami, A; Sagara, Y; Tamura, A | 1 |
Inoue, Y; Ishii, H; Ito, M; Ito, T; Kimino, K; Kishikawa, M; Kohno, S; Nakashima, M; Oka, M | 1 |
Boes, GH; Colombo, N; De Oliveira, CF; Lacave, AJ; Teodorovic, I; van der Burg, ME; Vermorken, JB; Zanetta, G | 1 |
Babović, N; Elezar, E; Gavrilović, D; Jelić, S; Kovacević, S; Kovcin, V; Mitrović, L; Radosavljević, D; Radulović, S; Tomasević, Z | 1 |
Akira, M; Atagi, S; Hosoe, S; Kawaguchi, T; Kawahara, M; Mitsuoka, S; Naka, N; Ogawara, M; Okishio, K; Sunami, T | 1 |
Eguchi, K; Iemura, K; Kojima, A; Miya, T; Ohe, Y; Okamoto, H; Oshita, F; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
Asamoto, H; Fukuoka, M; Furuse, K; Kimura, I; Niitani, H; Sakuma, A; Yamaguchi, Y | 1 |
Karato, A; Miya, T; Saijo, N; Sasaki, Y | 1 |
Hikita, M; Kobayashi, M; Kohno, K; Saito, T; Sato, S; Takano, H | 1 |
Komeyama, K; Nishiyama, T; Sato, S; Takahashi, E; Tanikawa, T; Terunuma, M; Tomita, Y | 1 |
Armand, JP; Bachouchi, M; Cvitkovic, E; Guillot, T; Kac, J; Luboinski, B; Munck, JN; Spielmann, M; Tellez-Bernal, E | 1 |
Doi, O; Higashiyama, M; Kodama, K; Koyama, H; Noguchi, S; Yokouchi, H | 1 |
Kanamaru, R; Kikuchi, H | 1 |
Arriagada, R; de Cremoux, H; Douillard, JY; Laplanche, A; Le Chevalier, T; Pignon, JP; Quoix, E; Ruffie, P; Tarayre, M | 1 |
Miyazawa, N; Mori, K; Saito, Y; Tominaga, K; Yokoi, K | 1 |
Beutter, P; Calais, G; Garand, G; Le Floch, O; Reynaud-Bougnoux, A | 1 |
Bains, M; Beitler, J; Burt, M; Chapman, D; Heelan, R; Hilaris, B; Kelsen, DP; Minsky, B; Niedzwiecki, D; Smith, M | 1 |
Aso, H; Hara, N; Ichinose, Y; Kuda, T; Motohiro, A; Ohta, M | 1 |
Endo, M; Ito, K; Sunagawa, M; Suzuki, T | 1 |
Armand, JP; Belehradek, M; Cvitkovic, E; De Vathaire, F; Domenge, C; Recondo, G; Richard, JM; Tellez-Bernal, E; Wibault, P | 1 |
Doi, R; Kihira, S; Kume, T; Nakao, M; Oshima, W; Takada, A; Takegami, E; Terazono, T | 1 |
Brambs, HJ; Drings, P; Kauffmann, G; Rieber, A; Wannenmacher, M | 1 |
Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A | 1 |
Ando, N; Ida, H; Iizuka, T; Kakegawa, T; Takagi, I; Watanabe, H | 1 |
Bauer, J; Capasso, P; Leyvraz, S; Pasche, P; Perey, L; Savary, M | 1 |
Fujii, T; Fujita, Y; Fukabori, T; Goto, T; Hiramori, N; Iwasaki, Y; Kida, T; Nakagawa, M; Nakamura, T | 1 |
Fujii, M; Genba, K; Matsutomo, S; Segawa, Y | 1 |
Bartolucci, A; Birch, R; Einhorn, LH; Greco, FA; Johnson, DH; Omura, G; Perez, CA | 1 |
Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Suzuki, A | 1 |
Allmayer, H; Klocker, J; Rab, B; Schumer, J; Tidstrand, J | 1 |
Armand, JP; Benhamed, M; Cvitkovic, E; Domenge, C; Guillot, T; Izzo, J; Recondo, G; Tellez-Bernal, E | 1 |
Beyer, JH; Borghardt, J; Foth, B; Gerhartz, H; Kastenbauer, E; Nagel, GA; Scherpe, A; Schröder, M; von Heyden, HW; Westerhausen, M | 1 |
Advani, SH; Desai, PB; Dinshaw, KA; Gopal, R; Pinto, JM; Saikia, TK; Sharma, S; Swaroop, VS; Vyas, JJ | 1 |
Bartolucci, AA; Dinwoodie, WR; Lyman, GH; Martelo, OJ; Sarma, PR; Velez-Garcia, E | 1 |
Nagel, GA; Scherpe, A; Schröder, M; von Heyden, HW | 1 |
Breau, JL; Clavier, J; Gres, JJ; Israël, L; Lerebours-Pigeonnière, G; Morère, JF; Nouvet, G; Raut, Y; Zabbe, C | 1 |
Fukui, H; Hanyu, F; Ide, H; Ikemoto, H; Murata, Y; Okushima, N; Sato, Y; Yamada, A | 1 |
Inoue, F; Mimura, H; Miyake, M; Mori, T; Orita, K; Takeda, I; Tanaka, N | 1 |
Flanagan, MM; Graeber, GM; Pass, HI; Rosenberg, JC; Roth, JA; Steinberg, S | 1 |
Herfarth, C; Herrmann, R; Lehner, B; Raeth, U; Schlag, P; Schwarz, V | 1 |
Hayashibara, K; Hirosawa, A; Niitani, H; Tsuboi, E | 1 |
Esumi, H; Hayasaka, K; Ikeda, S; Ikegawa, S; Ishihara, K; Kiyohara, Y; Obayashi, H; Saida, T; Sasaki, A | 1 |
Ando, N; Ide, H; Ishida, K; Kakegawa, T; Lizuka, T; Mori, S; Nashimoto, A; Sasaki, K; Takagi, I; Watanabe, H | 1 |
Andrieu, JM; Delaisements, C; Marin, I | 1 |
Egawa, T; Hiraki, S; Ishii, J; Kawahara, S; Ohnoshi, T; Tamai, M; Tamura, T; Ueoka, H; Yamashita, H; Yonei, T | 1 |
Becker, H; Bülzebruck, H; Djawid, N; Drings, P; Ruchalla, E; Stiefel, P; Tessen, HW | 1 |
Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M | 1 |
Burke, MT; Casper, ES; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG | 1 |
Drings, P; Manke, HG | 1 |
Eguchi, K; Fujita, J; Futami, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
Eguchi, K; Fujita, J; Futami, H; Ishihara, J; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Takahashi, H; Tominaga, K | 1 |
Berchet, JL; Cervantes, P; Feintrenie, X; Lamaze, R; Lamy, P; Vespignani, H | 1 |
Fukuda, Y; Homma, T; Nakata, M; Noguchi, Y; Sakura, M; Yoneda, S; Yoshida, S | 1 |
De Vries, EG; Meijer, C; Mulder, NH; Postmus, PE | 1 |
Marneur, M; Szpirglas, H; Vaillant, JM | 1 |
Hasegawa, M; Miyashita, K; Muto, T; Sasaki, K; Suzuki, S; Suzuki, T; Tanaka, O | 1 |
Bertin, F; Elias, D; Eschwege, F; Girinsky, T; Kac, J; Lasser, P; Leclercq, B; Nitenberg, G; Rougier, P; Spielmann, M | 1 |
Atsumi, M; Fuse, Y; Kataoka, K; Takeda, S; Takino, T; Taniwaki, M; Tsuji, T | 1 |
Andrieu, JM; Brzecka, A; Marin, I | 1 |
Bott, SJ; Prince-Fiocco, MA; Stewart, FM | 1 |
Barrelet, L; Bernasconi, S; Leyvraz, S; Savary, M | 1 |
Davidson, KG; Faichney, A; Moyes, P; Nicol, A; Simmonds, AP | 1 |
Bagin, R; Burke, MT; Casper, ES; Cibas, IR; Gralla, RJ; Groshen, S; Heelan, RT; Kalman, LA; Kelsen, DP; Kris, MG | 1 |
Bains, M; Coonley, C; Fein, R; Heelan, R; Kelsen, DP | 1 |
Birch, R; Enas, G; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
Aisner, J; Fuks, JZ; Hornedo, J; Patel, H; Van Echo, DA | 1 |
Arriagada, R; Baldeyrou, P; Duroux, P; Le Chevalier, T; Martin, M; Rouesse, J; Ruffié, P; Tarayre, M | 1 |
Arriagada, R; Baldeyrou, P; Duroux, P; Jacquotte, A; Le Chevalier, T; Martin, M; Rouesse, J; Sancho-Garnier, H | 1 |
Allan, SG; Carmichael, J; Compton, GK; Cornbleet, MA; Grant, IW; Gregor, A; Leonard, RC; McIntyre, MA; Smyth, JF | 1 |
Caille, P; Elias, D; Kac, J; Lasser, P; Le Chevalier, T; Rouesse, J; Rougier, P; Spielmann, M; Zummer, K | 1 |
Copeland, LJ; Gershenson, DM; Kavanagh, JJ; Saul, PB; Wharton, JT | 1 |
11 review(s) available for vindesine and Carcinoma, Epidermoid
Article | Year |
---|---|
Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lymphatic Metastasis; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 2014 |
Palliative cytostatic treatment of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Irinotecan; Mitomycin; Paclitaxel; Palliative Care; Randomized Controlled Trials as Topic; Survival Analysis; Uterine Cervical Neoplasms; Vindesine | 2003 |
Management of non-small-cell cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Prognosis; Vinblastine; Vincristine; Vindesine | 1984 |
Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine | 1983 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine | 1984 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
[Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Radiotherapy, Adjuvant; Vindesine | 1995 |
[A case of thymic carcinoma successfully controlled by combined chemotherapy and irradiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Male; Mitomycins; Radiotherapy Dosage; Thymus Neoplasms; Vindesine | 1995 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
A solitary bronchial papilloma with malignant changes.
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Bronchial Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Contraindications; Disease Progression; Electrosurgery; Humans; Keratins; Male; Mitomycin; Neoplasm Proteins; Papilloma; Parkinson Disease, Secondary; Pneumonectomy; Pulmonary Atelectasis; Serpins; Tomography, X-Ray Computed; Vindesine | 2001 |
51 trial(s) available for vindesine and Carcinoma, Epidermoid
Article | Year |
---|---|
Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Tegafur; Vindesine | 2005 |
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Humans; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2007 |
[Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Topics: Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Methotrexate; Prognosis; Vinblastine; Vindesine | 1981 |
[Preliminary results of a chemotherapy study of patients with squamous cell carcinoma in the head and neck region. Comparison of 2 therapeutic regimens: cis-diamminodichloroplatinum (II) and bleomycin compared to methotrexate and vindesine].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Vinblastine; Vindesine | 1981 |
[2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Time Factors; Vinblastine; Vindesine | 1983 |
[Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Methotrexate; Middle Aged; Vinblastine; Vindesine | 1984 |
[Indications for cytostatic therapy of recurrent cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Germany, West; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Vinblastine; Vindesine | 1984 |
[Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Methotrexate; Neoplasm Staging; Prognosis; Vinblastine; Vindesine | 1984 |
Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Prognosis; Vinblastine; Vindesine | 1983 |
Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Random Allocation; Vinblastine; Vindesine | 1983 |
A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Random Allocation; Vinblastine; Vindesine | 1983 |
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Mitoguazone; Vinblastine; Vindesine | 1984 |
[Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1984 |
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation; Vinblastine; Vindesine | 1984 |
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Time Factors; Vinblastine; Vindesine | 1981 |
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Platinum; Vindesine | 1993 |
[Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate; Vindesine | 1995 |
Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Palliative Care; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Survival Rate; Vindesine | 1993 |
[A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fever; Humans; Injections, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine | 1995 |
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Delivery Systems; Humans; Lung Neoplasms; Middle Aged; Phosphoramide Mustards; Postoperative Care; Prognosis; Survival Analysis; Vindesine | 1994 |
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Radiotherapy; Radiotherapy Dosage; Remission Induction; Stomatitis; Survival Rate; Vindesine | 1994 |
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Life Tables; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Vindesine | 1994 |
Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Survival Analysis; Vindesine | 1993 |
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diaphragm; Female; Humans; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Pleural Neoplasms; Prognosis; Vindesine | 1995 |
A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Time Factors; Vindesine | 1996 |
Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Confidence Intervals; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Rate; Time Factors; Vindesine; Weight Loss | 1995 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Prospective Studies; Survival Analysis; Vindesine | 1997 |
Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Survival Rate; Vindesine | 1998 |
Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Preoperative Care; Prospective Studies; Vindesine | 1999 |
[An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vindesine | 2000 |
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Europe; Female; Humans; Middle Aged; Mitomycin; Prospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vindesine | 2001 |
Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; Vindesine | 2001 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Dosage; Survival Rate; Treatment Failure; Vindesine | 2002 |
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Vindesine | 1992 |
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Fé
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vindesine | 1991 |
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Preoperative Care; Randomized Controlled Trials as Topic; Remission Induction; Vindesine | 1990 |
Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Peplomycin; Ploidies; Prognosis; Vindesine | 1991 |
Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1991 |
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiation Injuries; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 1990 |
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Random Allocation; Vinblastine; Vindesine | 1985 |
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Humans; Postoperative Complications; Random Allocation; Vindesine | 1988 |
Preoperative (neoadjuvant) chemotherapy in squamous cell cancer of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Follow-Up Studies; Humans; Preoperative Care; Vindesine | 1988 |
Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Topics: Adenocarcinoma; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Humans; Kidney; Lung Neoplasms; Platinum; Random Allocation; Thiosulfates; Time Factors; Vindesine | 1989 |
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Random Allocation; Vinblastine; Vindesine | 1985 |
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Creatinine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Peripheral Nervous System Diseases; Thrombocytopenia; Vinblastine; Vindesine | 1985 |
Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Nausea; Time Factors; Vinblastine; Vindesine | 1985 |
[A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Random Allocation; Vindesine | 1986 |
[Vindesine in oral cancers].
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Vinblastine; Vindesine | 1985 |
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platelet Count; Random Allocation; Vinblastine; Vindesine | 1985 |
92 other study(ies) available for vindesine and Carcinoma, Epidermoid
Article | Year |
---|---|
Evidence based analysis of Cisplatin for treating patients with cutaneous squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Salvage Therapy; Skin Neoplasms; Survival Rate; Vindesine | 2014 |
Induction chemotherapy before operation for multiple endobronchial squamous cell carcinoma of the lung.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Treatment Outcome; Vindesine | 2002 |
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine | 2002 |
[Cost-effectiveness analysis: a reader's guide].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Cost-Benefit Analysis; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine | 2003 |
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Empyema, Pleural; Female; Forced Expiratory Volume; Forecasting; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Pneumonia; Postoperative Complications; Predictive Value of Tests; Pulmonary Atelectasis; Pulmonary Diffusing Capacity; Pulmonary Embolism; Pulmonary Gas Exchange; Radiotherapy; Remission Induction; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Vinblastine; Vindesine; Vinorelbine; Vital Capacity | 2006 |
Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Humans; Immunohistochemistry; Lung Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53; Vindesine | 2007 |
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2008 |
[Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Vinblastine; Vindesine | 1984 |
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Topics: Acute Kidney Injury; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Vinblastine; Vindesine | 1982 |
Advances in chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Male; Middle Aged; Palliative Care; Prognosis; Smoking; United States; Vinblastine; Vindesine | 1981 |
Treatment of esophageal carcinoma combined preoperative chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Esophageal Neoplasms; Esophagus; Female; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Vinblastine; Vindesine | 1982 |
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kidney Diseases; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Vinblastine; Vindesine | 1983 |
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Neoplasm Staging; Radiography; Vinblastine; Vindesine | 1983 |
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vinblastine; Vindesine | 1983 |
[The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Carcinoembryonic Antigen; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Peplomycin; Vinblastine; Vincristine; Vindesine | 1984 |
Vindesine in bronchogenic carcinoma: a phase II trial.
Topics: Adenocarcinoma; Aged; Anemia; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cellulitis; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Nervous System; Phlebitis; Thrombocytosis; Vinblastine; Vindesine | 1982 |
Vindesine in the treatment of squamous cell carcinoma (WHO I), adenocarcinoma (WHO III), and large cell carcinoma (WHO IV) of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
[Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Vinblastine; Vindesine | 1982 |
Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paresthesia; Vinblastine; Vindesine | 1983 |
[Combination chemotherapy of nicardipine and vindesine sulfate, cis-diammine dichloroplatinum (II) for patients with advanced esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Carcinoma, Squamous Cell; Circadian Rhythm; Cisplatin; Drug Administration Schedule; Drug Resistance; Drug Synergism; Esophageal Neoplasms; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Nicardipine; Nifedipine; Vinblastine; Vindesine | 1984 |
[Cis-dichlorodiammine platinum (II) CDDP in the treatment of non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1984 |
Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Nervous System; Thrombocytopenia; Vinblastine; Vindesine | 1984 |
Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Middle Aged; Neutropenia; Vinblastine; Vindesine | 1984 |
Continuous vindesine infusion in advanced head and neck cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Male; Middle Aged; Vinblastine; Vindesine | 1983 |
Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nervous System; Neutropenia; Prognosis; Vinblastine; Vindesine | 1982 |
Vindesine: an effective agent in the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Alopecia; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1982 |
[Chemotherapy of head and neck squamous cell cancer with vindesine (Eldesine) and cis-platinum (Platinex) (author's transl)].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Vinblastine; Vindesine | 1982 |
Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: long-term results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Spain; Survival Analysis; Survival Rate; Time Factors; Vindesine | 1993 |
Combined application of cisplatin, vindesine, hyaluronidase and radiation for treatment of advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Vindesine | 1995 |
[A case of lung cancer with choroidal metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Choroid Neoplasms; Cisplatin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mitomycin; Vindesine | 1995 |
Lung cancer found in a patient with absence of the inferior vena cava associated with a left superior vena cava.
Topics: Aged; Angiography, Digital Subtraction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Congenital Abnormalities; Humans; Lung Neoplasms; Lymph Node Excision; Male; Mitomycin; Pneumonectomy; Tomography, X-Ray Computed; Venae Cavae; Vindesine | 1994 |
[Multidisciplinary treatment principles for improved QOL in patients with esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Humans; Lymph Node Excision; Quality of Life; Radiotherapy Dosage; Thoracotomy; Vindesine | 1993 |
[Antiemetic efficacy of granisetron in patients receiving 5-day continuous infusion of cisplatin].
Topics: Adenocarcinoma; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Granisetron; Humans; Indazoles; Infusions, Intra-Arterial; Lung Neoplasms; Male; Middle Aged; Nausea; Vindesine; Vomiting | 1993 |
Neoadjuvant chemotherapy with cisplatin-vindesine-5-fluorouracil and folinic acid for locally advanced head and neck carcinoma.
Topics: Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Survival Rate; Vindesine | 1996 |
[Thymic carcinoma effectively treated by preoperative concurrent chemo-radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Middle Aged; Preoperative Care; Radiotherapy Dosage; Thymus Neoplasms; Vindesine | 1996 |
[The usefulness of fibrin glue spraying combined with CDDP for lung cancer].
Topics: Adenocarcinoma; Adult; Aerosols; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fibrin Tissue Adhesive; Humans; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Nebulizers and Vaporizers; Vindesine | 1997 |
[Therapy pf cervical lymph node metastases of unknown primary tumor].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 1997 |
[A case of thymic carcinoma producing granulocyte colony-stimulating factor].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Male; Mitomycin; Thymus Neoplasms; Treatment Outcome; Vindesine | 1998 |
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vindesine | 1999 |
[Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Vindesine | 2000 |
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.
Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Sex Factors; Vindesine | 1992 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Uterine Cervical Neoplasms; Vindesine | 1992 |
Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; DNA Topoisomerases, Type II; Drug Resistance; Esophageal Neoplasms; Etoposide; Gene Expression; Glutathione Transferase; Humans; Membrane Glycoproteins; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine | 1992 |
[A case of advanced ureteral squamous cell carcinoma showing complete response to combination chemotherapy with cisplatinum, vindesine, and bleomycin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Middle Aged; Remission Induction; Ureteral Neoplasms; Vindesine | 1992 |
Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Retrospective Studies; Treatment Outcome; Vindesine | 1992 |
[Chemo-thermotherapy of radiation-induced squamous cell carcinoma in anterior chest wall].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Thoracic Neoplasms; Vindesine | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Stomach Neoplasms; Vindesine | 1992 |
[Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine].
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Vindesine | 1991 |
Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation--5 year results.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Middle Aged; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Radionuclide Imaging; Remission Induction; Retrospective Studies; Vincristine; Vindesine | 1990 |
Subrenal capsule assay as a chemosensitivity test for primary esophageal squamous cell carcinoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cell Division; Esophageal Neoplasms; Female; Fluorouracil; Humans; Immunohistochemistry; Mice; Middle Aged; Neoplasm Transplantation; Organoplatinum Compounds; Peplomycin; Subrenal Capsule Assay; Time Factors; Vindesine | 1991 |
Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Survival Analysis; Time Factors; Vindesine | 1991 |
[Neo-adjuvant chemotherapy with cisplatin, 5-fluorouracil, vindesine in head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Vindesine | 1992 |
[Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Middle Aged; Radiotherapy Dosage; Vindesine | 1991 |
[Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Humans; Ifosfamide; Kidney; Lung Neoplasms; Survival Rate; Vindesine | 1991 |
Cisplatin, vindesine, and 96-h continuous infusion of 5-fluorouracil as initial chemotherapy for locally advanced head and neck carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Synergism; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1991 |
[Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Vindesine | 1991 |
[Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Ifosfamide; Kidney; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine | 1990 |
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1990 |
[Cisplatin, vindesine and hyaluronidase combined with simultaneous radiotherapy of advanced head and neck tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyaluronoglucosaminidase; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Prospective Studies; Radiotherapy Dosage; Vindesine | 1990 |
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Survival Rate; Vindesine | 1990 |
The impact of combined therapeutic modalities in head, neck, and esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Radiotherapy Dosage; Vindesine | 1985 |
Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vindesine | 1986 |
[Effect of chemotherapy on the survival of patients with far-advanced squamous cell carcinoma of the head and neck. A comparative matched-pair analysis of conventional therapeutic procedures with and without chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prognosis; Vindesine | 1986 |
Preliminary results of preoperative chemotherapy with a combination of platinum-bleomycin administered in 5-day cycles in carcinoma of the bronchus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Platinum; Postoperative Complications; Vindesine | 1986 |
[A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Esophageal Neoplasms; Female; Humans; Male; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Vindesine | 1987 |
[Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Peplomycin; Vindesine | 1988 |
Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Female; Humans; Male; Middle Aged; Skin Neoplasms; Vindesine | 1989 |
A phase II study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vindesine | 1989 |
[Mediastinal carcinomas in young men without primary tumors. A chemosensitive entity?].
Topics: Adenocarcinoma, Mucinous; Adult; Carcinoma, Squamous Cell; Cisplatin; Humans; Male; Mediastinal Neoplasms; Middle Aged; Remission Induction; Vindesine | 1987 |
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vindesine | 1988 |
[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
Phase II study of vindesine in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Time Factors; Vindesine | 1985 |
[Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Vindesine | 1985 |
[Nontumoral nervous complications of bronchial cancer].
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Alcoholism; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cerebrovascular Disorders; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Nervous System Diseases; Paralysis; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Polyneuropathies; Vindesine | 1985 |
In vitro chemosensitivity of human lung cancer for vindesine.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Tumor Stem Cell Assay; Vindesine | 1987 |
[Remarkable effect of vindesine sulfate (VDS) in the treatment of metachronous lung metastasis of esophageal cancer--a case report].
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Period; Remission Induction; Vindesine | 1988 |
[Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Vindesine | 1988 |
[A complete response in squamous cell carcinoma of the lung to combination chemotherapy by cisplatin and vindesine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Humans; Lung Neoplasms; Male; Vindesine | 1987 |
[Early results of the treatment of non-small cell lung cancer using the PV3 protocol (cisplatin, vindesine and cobalt therapy)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1987 |
Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Prednisone; Pulmonary Fibrosis; Radiation Injuries; Vindesine | 1986 |
Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Vindesine | 1987 |
Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro.
Topics: Carcinoma, Squamous Cell; Cisplatin; Drug Resistance; Drug Synergism; Humans; In Vitro Techniques; Lung Neoplasms; Verapamil; Vindesine | 1986 |
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Mitoguazone; Neoplasm Metastasis; Vindesine | 1986 |
Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Vindesine | 1986 |
Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
[Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine | 1985 |
cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Male; Middle Aged; Vindesine | 1985 |
[Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Vindesine | 1985 |
Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Neutropenia; Uterine Cervical Neoplasms; Vindesine | 1985 |